No Data
Analysts Are Upgrading NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) After Its Latest Results
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), GH Research (GHRS) and NewAmsterdam Pharma Company (NAMS)
Express News | NewAmsterdam Pharma Company NV : Leerink Partners Cuts Target Price to $44 From $46
Express News | Needham Maintains Buy on NewAmsterdam Pharma Co, Lowers Price Target to $40
NewAmsterdam Pharma Co Analyst Ratings
Buy Rating Affirmed for NewAmsterdam Pharma: Strategic Progress and Financial Stability Drive Confidence